We are dedicated to the fight against skin cancer

utilizing an easy-to-implement, scalable, and novel diagnostic approach to save lives.

Our Optical Transfer Diagnostics - augmented AI technology

can make skin-cancer screenings more accurate, convenient, cost-effective and lead to higher detection rates and earlier detection of most types of skin cancer, resulting in better patient outcomes.

Our solution
  • Accurate
  • Convenient
  • Cost-efective

4
Globally granted patents

for AI technology to obtain vital information from skin sub-structures inspired by founders’ published work for NASA.

+250k
Commercial consultations

In Europe, primarily in pharmacies in collaboration with Walgreens Boots.

+1k
Melanomas identified

Contributing to the ongoing efforts in combating cancer.

99%
Sensitivity

Clinical studies shows that DeepX AI has world leading clinical performance.

A user-friendly Telederm solution

Next-gen handset in active development

  • Proprietary and affordable digital dermatoscope
  • Operated by a medical professional
  • Wireless
  • High-quality clinical and dermoscopic images
  • Completely compatible with DeepX AI

State-of-the-art software developed

  • Already actively being used in clinical collaborations including Mayo Clinic and the VA
  • Build from the ground-up for EHR integration
  • Diagnosis by a remote specialist reader
  • Optimized user experience

Benefits

  • Reduced time on diagnosis
  • Less false negatives
  • Reduced cost per-patient diagnosed
  • Reduced cost of treatment
  • Easy integration with AI diagnosis
  • FDA cleared
Request a demo

AI is our north star

Our device offers non-invasive, accurate screening to improve detection and reduce healthcare costs.

DeepX world’s most accurate AI for efficient, cost-effective skin cancer diagnosis.

DeepX is set to release its patented AI technology as a Class II medical device.

Algorithm data gathering collaboration for DeepX AI with the Mayo Clinic and Veterans Administration (VA).

DermoSight™

Makes an impact on patients' lives

Skin cancer is the most prevalent cancer in the world. We see beneath the skin to improve patient care, save costs and lives.

5 min.

Fast Consultations

Toke 5 minutes to submit a lesion for review.

1-2 days

Quick and Easy Process

24-48 hours on average to return results.

88 %

High Satisfaction Rate

88% of patients would use this service again.

95 %

Highly Recommended

95% would recommend the service to others.

DermoSight™ with DeepX AI will enable the most accurate and advanced optical transfer and artificial intelligence diagnostics.

We would love to hear from you!

Contact us now